KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Treasury Shares (2018 - 2025)

ClearPoint Neuro's Treasury Shares history spans 3 years, with the latest figure at $1.7 million for Q3 2013.

  • For Q3 2013, Treasury Shares changed 0.0% year-over-year to $1.7 million; the TTM value through Sep 2013 reached $1.7 million, changed 0.0%, while the annual FY2012 figure was $1.7 million, 0.0% changed from the prior year.
  • Treasury Shares for Q3 2025 was $16341.0 at ClearPoint Neuro, down from $1.7 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.9 million in Q1 2021 and bottomed at $16341.0 in Q3 2025.
  • The 5-year median for Treasury Shares is $399932.0 (2022), against an average of $663507.6.
  • The largest YoY upside for Treasury Shares was 0.0% in 2012 against a maximum downside of 0.0% in 2012.
  • A 3-year view of Treasury Shares shows it stood at $1.7 million in 2011, then changed by 0.0% to $1.7 million in 2012, then changed by 0.0% to $1.7 million in 2013.
  • Per Business Quant, the three most recent readings for CLPT's Treasury Shares are $1.7 million (Q3 2013), $1.7 million (Q2 2013), and $1.7 million (Q1 2013).